Literature DB >> 7611226

Canities and vitiligo complicating interferon therapy for hepatitis C.

D Bernstein1, K R Reddy, L Jeffers, E Schiff.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7611226

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

1.  Vitiligo improvement in a hepatitis C patient after treatment with PEG-interferon alpha-2a and ribavirin: a case report.

Authors:  M Taffaro; N Pyrsopoulos; H Cedron; E Cacayorin; D Weppler; J Moon; S Nishida; D Levi; T Kato; G Selvaggi; A Tzakis; E Schiff
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

2.  Vitiligo at Injection Site of PEG-IFN-α 2a in Two Patients with Chronic Hepatitis C: Case Report and Literature Review.

Authors:  V Arya; M Bansal; L Girard; S Arya; A Valluri
Journal:  Case Rep Dermatol       Date:  2010-08-27

Review 3.  Concise review of recent studies in vitiligo.

Authors:  Mohamed Allam; Hassan Riad
Journal:  Qatar Med J       Date:  2013-12-23

4.  Observational descriptive study of cutaneous manifestations in patients from Mato Grosso with viral chronic hepatitis.

Authors:  Renato Roberto Liberato Rostey; Francisco José Dutra Souto
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.